Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 1
1990 2
1992 4
1993 3
1994 1
1997 1
1999 1
2000 4
2001 1
2002 4
2003 1
2004 4
2005 5
2007 1
2011 1
2012 3
2013 7
2014 8
2015 2
2016 5
2017 4
2018 5
2019 13
2020 8
2021 4
2022 5
2023 4
2024 3
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
Brown JR, Seymour JF, Jurczak W, Aw A, Wach M, Illes A, Tedeschi A, Owen C, Skarbnik A, Lysak D, Eom KS, Šimkovič M, Pavlovsky MA, Kater AP, Eichhorst B, Miller K, Munugalavadla V, Yu T, de Borja M, Ghia P; AMPLIFY investigators; AMPLIFY Investigators. Brown JR, et al. Among authors: wach m. N Engl J Med. 2025 Feb 20;392(8):748-762. doi: 10.1056/NEJMoa2409804. Epub 2025 Feb 5. N Engl J Med. 2025. PMID: 39976417 Clinical Trial.
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Ghia P, Pluta A, Wach M, Lysak D, Kozak T, Simkovic M, Kaplan P, Kraychok I, Illes A, de la Serna J, Dolan S, Campbell P, Musuraca G, Jacob A, Avery E, Lee JH, Liang W, Patel P, Quah C, Jurczak W. Ghia P, et al. Among authors: wach m. J Clin Oncol. 2020 Sep 1;38(25):2849-2861. doi: 10.1200/JCO.19.03355. Epub 2020 May 27. J Clin Oncol. 2020. PMID: 32459600 Clinical Trial.
Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results.
Ghia P, Pluta A, Wach M, Lysak D, Šimkovič M, Kriachok I, Illés Á, de la Serna J, Dolan S, Campbell P, Musuraca G, Jacob A, Avery EJ, Lee JH, Usenko G, Wang MH, Yu T, Jurczak W. Ghia P, et al. Among authors: wach m. Hemasphere. 2022 Nov 14;6(12):e801. doi: 10.1097/HS9.0000000000000801. eCollection 2022 Dec. Hemasphere. 2022. PMID: 36398134 Free PMC article.
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growth.
Sinha S, Panda AK, Xavier das Neves R, Nwosu ZC, Xu K, van Beek E, Desai PP, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi AJ, Ayabe RI, Wach MM, McDonald JD, Ruff SM, Verbus EA, Saif A, Eade AV, Larrain CM, Friedman LR, Gupta S, Ranjan A, Teke ME, Khan TM, Pu T, Sarvestani AL, Ryan CE, Lambdin JT, Luberice K, Gregory SN, Lux SC, Hong H, Luna AJ, Alexander IA, Akmal SR, Rehman SU, Rainey A, Prickett TD, Koparde VN, Sevilla S, Kuhn SA, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam MC, Wu X, Jenkins LM, Blakely AM, Davis JL, Trinchieri G, Singh PK, Yang JC, Pasca di Magliano M, Lyssiotis CA, Yaffe MB, Shevach EM, Hernandez JM. Sinha S, et al. Among authors: wach mm. Cancer Discov. 2025 Jul 31. doi: 10.1158/2159-8290.CD-24-1055. Online ahead of print. Cancer Discov. 2025. PMID: 40736016
Intraperitoneal Chemotherapy: A Call to Study Reproductive Safety for Healthcare Workers.
Gupta P, Godfrey EL, Schultz KS, Yu LJ, Bansal VV, Gomez-Mayorga J, Papageorge M, Proussaloglou EM, Su DG, Merl MY, Ward E, Sood D, Magge DR, Senthil M, Kopecky KE, Turaga KK, Sarpel U; Peritoneal Surface Malignancies (PSM) Consortium Group. Gupta P, et al. Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18051-9. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40877725 No abstract available.
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases.
Schultz KS, Bansal VV, Wach MM, Bhutiani N, Godley FA 4th, Wang JJ, Waheed MT, Buchheit JT, Papai E, Campbell S, Schleimer LE, Su DG, Turaga KK, Gunderson CG, White MG, Uppal A, Raghav KPS, Labow DM, Sarpel U, Shergill AP, Shen JP, Eng C, Foote MB, Baumgartner JM; Peritoneal Surface Malignancies (PSM) Consortium Group. Schultz KS, et al. Among authors: wach mm. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17363-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560497 Review.
Consensus guideline for the management of peritoneal mesothelioma.
Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK, Gunderson CG, Lee B, Nash GM, Hays JL, Raghav KP, Husain AL, Kluger MD, Zauderer MG, Kindler HL, Alexander HR; Peritoneal Surface Malignancies Consortium Group. Brown LM, et al. Cancer. 2025 Jul 1;131(13):e35868. doi: 10.1002/cncr.35868. Cancer. 2025. PMID: 40558081
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases.
Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y; Peritoneal Surface Malignancies (PSM) Consortium Group. Butensky SD, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17361-2. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560499 Review.
Consensus Guideline for the Management of Malignant Gastrointestinal Obstruction in Patients with Peritoneal Surface Malignancies.
Bansal VV, Godfrey EL, Sadjadi J, Bello RJ, Kwakman R, Abreu AA, Vudatha V, Sparkman BK, Freudenberger DC, Su DG, Turaga KK, Micic D, Malec M, Tun S, Polite B, Lambert LA, Greenbaum A, Gunderson CG, Smith TJ, Kopecky KE, Powers BD, Maduekwe UN, Ward EP; Peritoneal Surface Malignancies (PSM) Consortium Group. Bansal VV, et al. Ann Surg Oncol. 2025 Jun 25. doi: 10.1245/s10434-025-17362-1. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40560502 Review.
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth.
Sinha S, Panda AK, Xavier das Neves R, Nwosu ZC, Xu K, van Beek E, Desai PP, Sindiri S, Chempati S, Remmert K, Gasmi B, Bojmar L, Zambirinis C, Rossi AJ, Ayabe RI, Wach MM, McDonald JD, Ruff SM, Verbus EA, Saif A, Eade AV, Larrain CM, Friedman LR, Gupta S, Ranjan A, Teke ME, Khan TM, Pu T, Sarvestani AL, Ryan CE, Lambdin JT, Luberice K, Gregory SN, Lux SC, Hong H, Luna AJ, Alexander IA, Akmal SR, Rehman SU, Rainey A, Prickett TD, Koparde VN, Sevilla S, Kuhn SA, Chan K, Sun Z, Bubunenko N, Li E, Hannah C, Gaga G, Andresson T, Cam MC, Wu X, Jenkins LM, Blakely AM, Davis JL, Trinchieri G, Singh PK, Yang JC, Pasca di Magliano M, Lyssiotis CA, Yaffe MB, Shevach EM, Hernandez JM. Sinha S, et al. Among authors: wach mm. Cancer Discov. 2025 Sep 30:OF1-OF30. doi: 10.1158/2159-8290.CD-24-1055. Online ahead of print. Cancer Discov. 2025. PMID: 41025961
105 results